Italia markets open in 6 hours 22 minutes

Dow Jones
39.872,99
+66,22(+0,17%)
Nasdaq
16.832,62
+37,75(+0,22%)
Nikkei 225
38.688,44
-258,49(-0,66%)
EUR/USD
1,0861
+0,0002(+0,02%)
Bitcoin EUR
64.583,10
-1.108,61(-1,69%)
CMC Crypto 200
1.527,65
+39,10(+2,63%)

NVCR Jul 2024 22.500 put

OPR - OPR Prezzo differito. Valuta in USD.

Aggiungi a watchlist

2,4000

+0,8900

(+58,94%)

In data: 03:11PM EDT. Mercato aperto.

GlobeNewswire
Zai Lab and Novocure Announce LUNAR Phase 3 Clinical Trial Demonstrates Statistically Significant and Clinically Meaningful Extension in Overall Survival for Patients with Metastatic Non-Small Cell Lung Cancer After Platinum-Based Therapies
Tumor Treating Fields therapy together with standard of care provided a statistically significant and clinically meaningful 3-month improvement in median overall survival versus standard of care with no added systemic toxicities Tumor Treating Fields therapy together with immune checkpoint inhibitors resulted in an unprecedented 8-month improvement in median overall survival LUNAR is the first phase 3 clinical trial in more than seven years to show a significant extension in overall survival in